KalVista Pharmaceuticals, Inc. (KALV) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$7,970
Total Return
-20.30%
CAGR
-4.44%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.71% |
| Median | +0.51% |
| Best | +64.19% |
| Worst | -71.09% |
| % of Windows Positive | 51.8% |
1-Year (252 Trading Days)
| Average | +5.79% |
| Median | +2.88% |
| Best | +135.62% |
| Worst | -76.24% |
| % of Windows Positive | 53.8% |
3-Year (756 Trading Days)
| Average | +21.47% |
| Median | -17.24% |
| Best | +232.22% |
| Worst | -62.52% |
| % of Windows Positive | 39.1% |
Risk Metrics
| Maximum Drawdown | -85.96% |
| Average Drawdown | -56.91% |
| Drawdown Duration | 1214 Trading Days (Unrecovered) |
| Sortino Ratio | 0.40 |
| Calmar Ratio | -0.05 |
| CVaR (5%) | -8.01% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +20.31% (+83.75% ann.) | +$2030.97 | $0.00 | $0.00 | $0.00 |
| 2025 | +90.67% | +$9067.30 | $0.00 | $0.00 | $0.00 |
| 2024 | -30.86% | $3085.71 | $0.00 | $0.00 | $0.00 |
| 2023 | +81.21% | +$8121.25 | $0.00 | $0.00 | $0.00 |
| 2022 | -48.90% | $4890.39 | $0.00 | $0.00 | $0.00 |
| 2021 | -30.33% | $3033.18 | $0.00 | $0.00 | $0.00 |
| 2020 | +6.63% | +$662.54 | $0.00 | $0.00 | $0.00 |
| 2019 | -9.82% | $982.28 | $0.00 | $0.00 | $0.00 |
| 2018 | +102.56% | +$10256.43 | $0.00 | $0.00 | $0.00 |
| 2017 | +37.91% | +$3790.72 | $0.00 | $0.00 | $0.00 |
| 2016 | -86.05% | $8604.98 | $0.00 | $0.00 | $0.00 |
| 2015 partial | -34.89% (-44.53% ann.) | $3489.21 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | April 9, 2015 – February 19, 2020 | -81.32% | -29.17% | $8132.07 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -50.11% | -99.96% | $5010.59 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +121.61% | +259.81% | +$12161.48 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -18.80% | -17.93% | $1880.49 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -64.14% | -66.34% | $6413.79 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +91.14% | +41.84% | +$9113.92 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | +81.76% | +45.69% | +$8175.89 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.